ArticleFrontiers in medicine2026
Deep learning-based frame synthesis enables radiation dose reduction in digital subtraction angiography imaging: a multicenter study.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: As an important imaging tool for diagnosing and treating cerebrovascular diseases, the low-dose imaging technology of digital subtraction angiography (DSA) can effectively reduce radiation exposure risks for both patients and operators. To ensure clinical demand while minimizing radiation dose, this study proposed SAVE-Net, which integrates deep learning with optical flow estimation. The model is designed to synthesize intermediate frames in DSA sequences, thereby reducing the number of scans required in clinical practice and directly decreasing the radiation dose. Methods: SAVE-Net was developed to generate subsequent frames following any given real DSA frame. A total of 17,335 DSA sequences from one hospital were used for model training, fine-tuning, and internal validation. For external validation, an additional 3,255 DSA sequences from two other hospitals were utilized. Image similarity between generated and real frames was quantitatively evaluated using the Structural Similarity Index (SSIM) and Peak Signal-to-Noise Ratio (PSNR). Furthermore, five interventional radiologists independently performed a visual Turing test and quality assessment on the generated sequences. Inter-rater agreement for the Turing test results was assessed using Fleiss' Kappa, while the Wilcoxon Signed-Rank test was employed to analyze significant differences in the quality ratings. Results: Internal validation results demonstrated that SAVE-Net achieved DSA sequences highly consistent with real clinical data using only 1/7 of the standard radiation dose and maintained stable performance across multiple scenarios. External validation results illustrated that SAVE-Net achieved an effective performance [SSIM: 0.951, 95% CI: (0.948, 0.956); PSNR: 40.764, 95% CI: (40.673, 40.798); and generation time: 0.04 s/frame]. Assessment results showed no significant difference between the generated sequences and the real ones. Additionally, the generated results exhibited high consistency with real data in terms of overall image quality (4.919 vs. 4.940) and diagnostic confidence (4.838 vs. 4.910). Conclusion: SAVE-Net enables the generation of clinically diagnostic DSA sequences using only 1/7 of the standard radiation dose, with image quality and diagnostic confidence comparable to real clinical data. Its superior performance across multi-center validation demonstrates a practical and effective approach to reducing radiation exposure in cerebrovascular imaging.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.